Targeting Adaptive Stress and Innate Immunity
We have developed a deep and differentiated pipeline of therapies that address dynamic drivers of treatment resistance, cancer relapse and metastasis. We believe that this discovery approach supports our development of innovative molecules that can address some of the most significant unmet needs in cancer.